S. Pye

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

F. Lemonnier, A. Suhrbier, S. Elliott, 1999, Journal of Immunology.

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

F. Lemonnier, A. Suhrbier, S. Elliott, 1999, Journal of immunology.

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.

A. Suhrbier, S. Elliott, T. Le, 1999, Vaccine.

Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis

S. L. Silins, J. Burrows, S. Burrows, 1996, The Journal of experimental medicine.

Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

Andreas Suhrbier, John J Miles, S. Burrows, 2007, Journal of Virology.

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.

S. L. Silins, R. Khanna, I. Misko, 1999, Proceedings of the National Academy of Sciences of the United States of America.

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

F. Lemonnier, A. Suhrbier, S. Elliott, 1999, Journal of immunology.

Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

S. L. Silins, I. Misko, S. Elliott, 1997, The Journal of infectious diseases.

Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.

S. L. Silins, J. Burrows, D. Moss, 1997, International immunology.

Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis

S. L. Silins, J. Burrows, S. Burrows, 1996, The Journal of experimental medicine.